With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

Ozempic is a drug for ... of average weight loss of 3.7% one year after starting on medications, the overall reported magnitude of benefit was less than in reported trials. The new study examines ...

The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making ...

Doctors are already using weight loss drugs to treat binge eating disorder. But some experts warn that it’s a Band-Aid, not a ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat diabetes, ...